Identification and quantification of metabolites of AB-CHMINACA in a urine specimen of an abuser

Legal Medicine

Volumn 19, Issue , 2016, Pages 113-118

  Wurita, Amin ^a   Hasegawa, Koutaro ^a   Minakata, Kayoko ^a   Gonmori, Kunio ^a   Nozawa, Hideki ^a   Yamagishi, Itaru ^a   Suzuki, Osamu ^a   Watanabe, Kanako ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

4 Hydroxycyclohexylmethyl AB CHMINACA; AB CHMINACA metabolites; In vivo human metabolism; LC MS MS; Modified QuEChERS method; Quantification

Indexed keywords

1 (CYCLOHEXYLMETHYL) 1H INDAZOLE 3 CARBOXYLIC ACID; 1 [(4 HYDROXYCYCLOHEXYL)METHYL] 1H INDAZOLE 3 CARBOXYLIC ACID; 2 [1 (CYCLOHEXYLMETHYL) 1H INDAZOLE 3 CARBOXAMIDO] 3 METHYLSUCCINIC ACID; 4 AMINO 3 [1 (CYCLOHEXYLMETHYL) 1H INDAZOLE 3 CARBOXAMIDO] 2 METHYL 4 OXOBUTANOIC ACID; BETA GLUCURONIDASE; DRUG METABOLITE; N (1 AMINO 3 METHYL 1 OXOBUTAN 2 YL) 1 [(3 HYDROXYCYCLOHE XYL)METHYL] 1H INDAZOLE 3 CARBOXAMIDE; N (1 AMINO 3 METHYL 1 OXOBUTAN 2 YL) 1 [(4 HYDROXYCYCLOHEXYL)METHYL] 1H INDAZOLE 3 CARBOXAMIDE; N [[1 (CYCLOHEXYLMETHYL) 1H INDAZOL 3 YL]CARBONYL] LEVO VALINE; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG; [1 [(4 HYDROXYC YCLOHEXYL)METHYL] 1H INDAZOLE 3 CARBONYL] LEVO VALINE; INDAZOLE DERIVATIVE; N-(1-(AMINOCARBONYL)-2-METHYLPROPYL)-1-(CYCLOHEXYLMETHYL)-1H-INDAZOLE-3-CARBOXAMIDE; VALINE;

ACCURACY; ARTICLE; DRUG IDENTIFICATION; HUMAN; HUMAN TISSUE; HYDROLYSIS; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; PHYSICAL CHEMISTRY; TANDEM MASS SPECTROMETRY; URINALYSIS; ANALOGS AND DERIVATIVES; AUTOPSY; CASE REPORT; FORENSIC TOXICOLOGY; PROCEDURES; SUBSTANCE ABUSE; URINE;

AUTOPSY; CHROMATOGRAPHY, LIQUID; FORENSIC TOXICOLOGY; HUMANS; INDAZOLES; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY; VALINE;

EID: 84960315894     PISSN: 13446223     EISSN: 18734162     Source Type: Journal    
DOI: 10.1016/j.legalmed.2015.07.011     Document Type: Article

References (22)

1. Zuba D., Byrska B. Analysis of the prevalence and coexistence of synthetic cannabinoids in "herbal high" products in Poland. Forensic Toxicol. 2013, 31:21-30.
2. Kikura-Hanajiri R., Uchiyama N., Kawamura M., Goda Y. Changes in the prevalence of synthetic cannabinoids and cathinone derivatives in Japan until early 2012. Forensic Toxicol. 2013, 31:44-53.
3. Chung H., Choi H., Heo S., Kim E., Lee J. Synthetic cannabinoids abused in South Korea: drug identifications by the National Forensic Service from 2009 to June 2013. Forensic Toxicol. 2014, 32:82-88.
4. Uchiyama N., Shimokawa Y., Kawamura M., Kikura-Hanajiri R., Hakamatsuka T. Chemical analysis of a benzofuran derivative, 2-(2-ethylaminopropyl)benzofuran (2-EAPB), eight synthetic cannabinoids, five cathinone derivatives, and five other designer drugs newly detected in illegal products. Forensic Toxicol. 2014, 32:266-281.
5. Shima N., Katagi M., Kamata H., Matsuta S., Nakanishi K., Zaitsu K., et al. Urinary excretion and metabolism of the newly encountered designer drug 3,4-dimethylmethcathinone in humans. Forensic Toxicol. 2013, 31:101-112.
6. Namera A., Konuma K., Kawamura M., Saito T., Nakamoto A., Yahata M., et al. Time-course profile of urinary excretion of intravenously administered α-pyrrolidinovalerophenone and α-pyrrolidinobutiophenone in a human. Forensic Toxicol. 2014, 32:68-74.
7. Zaitsu K., Katagi M., Tsuchihashi H., Ishii A. Recently abused synthetic cathinones, α-pyrrolidinophenone derivatives: a review of their pharmacology, acute toxicity, and metabolism. Forensic Toxicol. 2014, 32:1-8.
8. Miserez B., Ayrton O., Ramsey J. Analysis of purity and cutting agents in street mephedrone samples from South Wales. Forensic Toxicol. 2014, 32:305-310.
9. Saito T., Namera A., Miura N., Ohta S., Miyazaki S., Osawa M., Inokuchi S. A fatal case of MAM-2201 poisoning. Forensic Toxicol. 2013, 31:333-337.
10. Namera A., Urabe S., Saito T., Torikoshi-Hatano A., Shiraishi H., Arima Y., Nagao M. A fatal case of 3,4-methylenedioxypyrovalerone poisoning: coexistence of α-pyrrolidinobutiophenone and α-pyrrolidinovalerophenone in blood and/or hair. Forensic Toxicol. 2013, 31:338-343.
11. Hasegawa K., Suzuki O., Wurita A., Minakata K., Yamagishi I., Nozawa H., et al. Postmortem distribution of α-pyrrolidinovalerophenone and its metabolite in body fluids and solid tissues in a fatal poisoning case measured by LC-MS-MS with the standard addition method. Forensic Toxicol. 2014, 32:225-234.
12. Hasegawa K., Wurita A., Minakata K., Gonmori K., Nozawa H., Yamagishi I., et al. Identification and quantitation of a new cathinone designer drug PV9 in an "aroma liquid" product, antemortem whole blood and urine specimens, and a postmortem whole blood specimen in a fatal poisoning case. Forensic Toxicol. 2014, 32:243-250.
13. Hasegawa K., Wurita A., Minakata K., Gonmori K., Yamagishi I., Nozawa H., et al. Identification and quantitation of 5-fluoro-ADB, one of the most dangerous synthetic cannabinoids, in the stomach contents, and solid tissues of a human cadaver and in some herbal products. Forensic Toxicol. 2015, 33:112-121.
14. Shintani-Ishida K., Nakamura M., Tojo M., Idota N., Ikegaya H. Identification and quantification of 4'-methoxy-α-pyrrolidinobutiophenone (4-MeOPBP) in human plasma and urine using LC-TOF-MS in an autopsy case. Forensic Toxicol. 2015, 33:348-354.
15. Hasegawa K., Wurita A., Minakata K., Gonmori K., Nozawa H., Yamagishi I., et al. Postmortem distribution of MAB-CHMINACA in body fluids and solid tissues of a human cadaver. Forensic Toxicol. 2015, 33:380-387.
16. Hasegawa K., Wurita A., Minakata K., Gonmori K., Nozawa H., Yamagishi I., et al. Postmortem distribution of AB-CHMINACA, 5-fluoro-AMB, and diphenidine in body fluids and solid tissues in a fatal poisoning case: usefulness of the adipose tissue for detection of the drugs in the unchanged forms. Forensic Toxicol. 2015, 33:45-53.
17. Jang M., Shin I., Kim J., Yang W. Simultaneous quantification of 37 synthetic cannabinoid metabolites in human urine by liquid chromatography-tandem mass spectrometry. Forensic Toxicol. 2015, 33:221-234.
18. C. Erratico, N. Negreira, H. Norouzizadeh, A. Covaci, H. Neels, K. Maudens, et al., In vitro and in vivo human metabolism of the synthetic cannabinoid AB-CHMINACA, Drug Test. Anal., . http://dx.doi.org/10.1002/dta.1796.
19. Bonilla E. Flameless atomic absorption spectrophotometric determination of manganese in rat brain and other tissues. Clin. Chem. 1978, 24:471-474.
20. Wurita A., Suzuki O., Hasegawa K., Gonmori K., Minakata K., Yamagishi I., et al. Sensitive determination of ethylene glycol, propylene glycol and diethylene glycol in human whole blood by isotope dilution gas chromatography-mass spectrometry, and the presence of appreciable amounts of the glycols in blood of healthy subjects. Forensic Toxicol. 2013, 31:272-280.
21. Wurita A., Hasegawa K., Minakata K., Gonmori K., Nozawa H., Yamagishi I., et al. Postmortem distribution of α-pyrrolidinobutiophenone in body fluids and solid tissues of a human cadaver. Leg. Med. 2014, 16:241-246.
22. Poklis J.L., Devers K.G., Arbefeville E.F., Pearson J.M., Houston E., Poklis A. Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death. Forensic Sci. Int. 2014, 234:e14-e20.